CA-125 IS AN EXCRETORY PRODUCT OF HUMAN ENDOMETRIAL GLANDS

被引:32
|
作者
WEINTRAUB, J
BISCHOF, P
TSENG, L
REDARD, M
VASSILAKOS, P
机构
[1] UNIV GENEVA,DEPT OBSTET & GYNECOL,CH-1211 GENEVA 4,SWITZERLAND
[2] SUNY STONY BROOK,DEPT OBSTET & GYNECOL,STONY BROOK,NY 11794
关键词
D O I
10.1095/biolreprod42.4.721
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The present investigation was undertaken to study the cellular localization and kinetics of synthesis of CA 125 in the endometrium. CA 125 was localized by immunohistochemistry to the infranuclear region of epithelial cells during the proliferative phase and to the apical luminal border during the secretory phase. In gestational endometrium, both the cytoplasm and the apical luminal border of epithelial cells were intensely positive. No staining was seen in endometrial stromal cells during the normal cycle or in decidualized endometria. Results obtained from in vitro cultures of separated glandular and stromal cells were similar to those obtained by immunohistochemistry. That is epithelial cells released between 5 and 25 times more CA 125 into the culture medium than did stromal cells. The release of CA 125 was highest in epithelial and stromal cells obtained during the early secretory phase. CA 125 concentrations were markedly elevated in endometrial aspirations obtained during the secretory phase or in endometria with crumbling stroma compared to plasma levels. Plasma levels of CA 125 were slightly elevated during menses. These results suggest that CA 125 is an exocrine product of endometrial epithelial cells. Plasma levels of CA 125 may be of endometrial origin only when the membrane barriers, which normally prevent its entry into the circulation, are damaged.
引用
收藏
页码:721 / 726
页数:6
相关论文
共 50 条
  • [1] CA-125 - A USEFUL MARKER IN ENDOMETRIAL CARCINOMA
    DUK, JM
    AALDERS, JG
    FLEUREN, GJ
    DEBRUIJN, HWA
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 155 (05) : 1097 - 1102
  • [2] ENDOMETRIAL ANTIBODIES VERSUS CA-125 FOR THE DETECTION OF ENDOMETRIOSIS
    WILD, RA
    PODCZASKI, ES
    HIRISAVE, V
    DEMERS, LM
    BIANCO, A
    FERTILITY AND STERILITY, 1991, 55 (01) : 90 - 94
  • [3] Serum CA-125 tumor marker in endometrial adenocarcinoma
    Kukura, V
    Zovko, G
    Ciglar, S
    Markulin-Grgic, L
    Santek, F
    Podgajski, M
    Duic, Z
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (02) : 151 - 153
  • [4] ` Correlation Between Tumor CA-125 Content and Preoperative Serum CA-125 Antigen Levels in Patients With Endometrial Cancer
    Metindir, Jale
    Bilir, Gulay
    Pak, Isin
    JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2006, 7 (04) : 313 - 318
  • [5] CONCENTRATIONS OF CA-125 TUMOR-MARKER IN ENDOMETRIAL CARCINOMA
    KUKURA, V
    ZANINOVIC, I
    HRDINA, B
    GYNECOLOGIC ONCOLOGY, 1990, 37 (03) : 388 - 389
  • [6] IS THERE A ROLE FOR CA-125 IN MONITORING PATIENTS WITH EARLY ENDOMETRIAL CANCER
    PREFONTAINE, M
    OCONNELL, GJ
    RYAN, E
    MURPHY, KJ
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1991, 1 (04) : 169 - 172
  • [7] RAISED SERUM LEVELS OF CA-125 IN PATIENTS WITH ENDOMETRIAL ADENOCARCINOMA
    DUK, MJ
    AALDERS, JG
    KOOI, H
    FLEUREN, GJ
    DEBRUIJN, HWA
    TUMOUR BIOLOGY, 1985, 6 (04): : 418 - 418
  • [8] Preoperative serum CA-125 levels in treating endometrial cancer
    Powell, JL
    Hill, KA
    Shiro, BC
    Diehl, SJ
    Gajewski, WH
    JOURNAL OF REPRODUCTIVE MEDICINE, 2005, 50 (08) : 585 - 590
  • [9] Usefulness of serial CA-125 levels in surveillance of endometrial cancer
    Pennington, K.
    Reynolds, R.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S97 - S97
  • [10] CA-125 LEVELS IN HUMAN UTERINE FLUID
    ABAE, M
    GIBSON, M
    CHAPITIS, J
    RIDDICK, DH
    BRUMSTED, JR
    FERTILITY AND STERILITY, 1992, 57 (03) : 531 - 534